Cargando…
Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure
It is well known that the natural history of chronic heart failure (CHF),regardless of age and aetiology,is characterized by progressive cardiac dysfunction refractory to conventional cardiokinetic, diuretic and peripheral vasodilator therapy. Several previous studies, both in animals and humans, sh...
Autores principales: | Distefano, Giuseppe, Sciacca, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480957/ https://www.ncbi.nlm.nih.gov/pubmed/22971785 http://dx.doi.org/10.1186/1824-7288-38-41 |
Ejemplares similares
-
Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn
por: Distefano, Giuseppe, et al.
Publicado: (2015) -
Biomarkers of Myocardial Injury and Remodeling in Heart Failure
por: Ponikowska, Barbara, et al.
Publicado: (2022) -
Relationship of Acylcarnitines to Myocardial Ischemic Remodeling and Clinical Manifestations in Chronic Heart Failure
por: Belenkov, Yuri N., et al.
Publicado: (2023) -
Editorial: Molecular and cellular mechanisms of heart failure: pathophysiology, pathogenesis and therapeutics
por: Lal, Sean, et al.
Publicado: (2023) -
Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
por: Mengstie, Misganaw Asmamaw, et al.
Publicado: (2022)